Valion Bio
VBIO
Valion Bio (VBIO) earnings history
Most recent quarter
- Fiscal period
- Q3 2024
- Period end
- Sep 30, 2024
- EPS actual
- −$97.75
- EPS estimate
- −$2,550.00
- EPS surprise
- +96.17%
- Revenue surprise
- −90.00%
- Revenue
- $126,000.00
- Revenue estimate
- $1.3M
- Reported
- Nov 14, 2024
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2024 | Nov 14, 2024 | −$2,550.00 | −$97.75 | +96.17% | $126,000.00 | SEC |
| Q2 2024 | Aug 14, 2024 | −$2,550.00 | −$136.00 | +94.67% | $140,000.00 | SEC |
| Q1 2024 | May 15, 2024 | −$2,975.00 | −$429.25 | +85.57% | $334,000.00 | SEC |
| Q4 2023 | Mar 25, 2024 | −$2,975.00 | $3,859.00 | +229.71% | $356,000.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$2,975.00 | −$629.00 | +78.86% | $282,000.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$3,400.00 | −$2,975.00 | +12.50% | $161,000.00 | SEC |
| Q1 2023 | May 15, 2023 | −$4,675.00 | −$4,675.00 | +0.00% | $376,000.00 | SEC |
| Q4 2022 | Mar 31, 2023 | −$13,175.00 | −$9,775.00 | +25.81% | $400,000.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$13,600.00 | −$11,475.00 | +15.63% | $477,000.00 | SEC |
| Q2 2022 | Aug 15, 2022 | −$10,200.00 | −$13,600.00 | −33.33% | $528,000.00 | SEC |
| Q1 2022 | May 16, 2022 | $0.00 | −$9,775.00 | +0.00% | $430,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Valion Bio (VBIO) last report earnings?
Valion Bio last reported on Nov 14, 2024, covering fiscal Q3 2024.
Did VBIO beat earnings estimates?
Yes. Valion Bio reported EPS of −$97.75 for Q3 2024 against a −$2,550.00 estimate — a 96.17% beat.
How much revenue did VBIO report last quarter?
Valion Bio reported $126,000.00 in revenue for Q3 2024, against a consensus estimate of $1.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.